Home » Newsletters » BioWorld Science

BioWorld Science

March 25, 2003

View Archived Issues

Gabapentin combined with valaciclovir reduces severity and duration of postherpetic neuralgia

MBI-594AN solution safe and effective for reducing acne lesions

Long-lasting antitumor activity reported for Bexxar in refractory B-cell lymphoma

Combination therapy containing zosuquidar reverses multidrug resistance in AML

New data on subantimicrobial doses of Periostat discussed in San Antonio

New PARP inhibitors prepared and tested at Guilford

Pharma Mar identifies new antitumor ecteinascidin derivatives

Novel series of sPLA2 inhibitors described in Lilly patent

Takeda claims new CCR5 antagonists for HIV infection and other uses

Actelion scientists present novel series of endothelin antagonists

Benzopyran beta3-adrenoceptor agonists in Glenmark development pipeline

NeuroSearch describes novel inhibitors of CNS monoamine uptake

Potent alpha-adrenoceptor antagonists with utility in sexual dysfunction

Novel GnRH antagonists discovered by Neurocrine scientists

Lilly advances LY-818 into phase II

GL-48656 preclinical data reported

Galen's Femring approved by U.S. FDA

Incyte Genomics completes acquisition of Maxia

Vernalis reviews 2002 developments

Chronic antagonism of the CB1 receptor results in antiobesity effects in mice

Albaconazole, a broad-spectrum antifungal agent with a favorable overall profile

Methods of prophylaxis and treatment of HER-2/neu tumors

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...